The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation

<div><i>KJS018A suppresses PMA-promoted inflammation in hepatic malignant cells via inhibiting Cox-2/IL-6 axis.</i> (a) Western blotting of SNU398 and HepG2 after 150 <i>μ</i>g/mL KJS018A treatment for 24 h with or without 100 ng/mL PMA activation. (b) Attenuation of IL-6 and Cox-2 in SNU398 and HepG2 after 24 h exposing 50 <i>μ</i>g/mL KJS018A, visualized by immunocytochemistry staining. Scale bar, 20 <i>μ</i>m.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation 